Diet Pills and the FDA

Pills and the

Each year, millions of Americans resolve to it is one of the most common New Year’s resolutions. Many people start off with great intentions, but within months, weeks, or even days, most of them give up and return to their usual habits. If they work to the possibility exists that they might end up regaining any weight they lost. Americans spend up to $30 billion each year on various methods of weight and often see little improvement for their investment. Money is spent on gym memberships, exercise equipment, and weight supplements.7 For many the only way they can get on the road to successful weight is though the use of drugs or other medical interventions.

Over the years, experts’ rationale for incorporating drugs into established guidelines has changed. There are several reasons for this. Top among these are that experts realize that and overweight are major problems, and can develop into lifelong diseases. These factors indicate that is a chronic (long-term) disease. who are obese often remain obese or overweight as adults. This chapter focuses on the use, risks, and benefits of prescription drugs that are approved by the for weight

QUALIFYING FOR DRUG THERAPY

For an overweight or obese person to qualify for drug therapy, he or she must meet certain criteria. These are:

News Acomplia Zimulti FDA

News Acomplia

Pills and the

When people are obese, there are a number of concerns that are more serious than just looking large on the outside. On the inside, many of the body’s organs are affected due to increased weight, some of which are illustrated here. Being overweight can also lead to high blood pressure and high cholesterol, both of which can cause someone to have a or stroke.

  1. The patient must have a BMI greater than 30 kg/m2.
  2. The patient must have a BMI greater than 27 kg/m2

and risk factors for:

3. The patient must have a waist circumference greater

than 35 inches (89 cm) for women or 40 inches
(102 cm) for men, and the risk factors stated above.

It is important to realize that people who qualify for drugtherapy do so based on considerations and risk factors, not simply because they want to improve their appearance. Drug therapy is not undertaken for cosmetic reasons and should never be regarded as a shortcut or “springboard” to weight Healthy and exercise are the keys to weight

drugs alone will not produce weight A patient must be engaged in an appropriate weight program that includes regular exercise. If someone wishes to over the long term, he or she must be committed to staying on his or her weight program. drugs are not the “be all, end all” of weight

HOW THE APPROVES DRUGS

The s approval process for new prescription drugs is extensive. It can take over ten years for a drug to reach the market. Before receiving approval, a new drug must be studied extensively. The process begins with the discovery or development of a new substance that can be used for medicinal purposes. The potential drug is first studied in a laboratory, then in animals. It is then studied in healthy adults to see what it produces and to determine how it works in the body. In the next phase of studies, the drug is given to a large number of people who are “sick,” to see if the drug is effective.

If the drug passes through these rounds of testing, it is subjected to a thorough review by an advisory committee, which determines from all of the information the company submits whether or not the drug works. Considerable emphasis is also put on the safety of this new drug. If the drug passes the s review, it can be put on the market. The result of this extensive review process is, ideally, a new, effective, safe drug that can help a person combat a disease (such as that can result in very serious outcomes.


Метки:, , , , , , , , , , , , , , , , ,

Посмотрите также

If you enjoyed this post, please consider to leave a comment or subscribe to the feed and get future articles delivered to your feed reader.

Comments

Еще нет комментариев.

Извините, комментирование на данный момент закрыто.

News Acomplia Zimulti